Genomics Services Reach Cogenics offers a broad suite of genomic services for both research and regulated projects, creating opportunities to cross-sell integrated DNA/RNA extraction, sequencing, genotyping, QPCR, and biorepository services to biotech, pharma, and academic clients.

Global Footprint With facilities in the US and Europe (Texas, North Carolina, UK, France, Germany) and a 200+ employee base, there is potential to pursue multinational collaborations, transfer partnerships, and cross-border project work with global sponsors.

Pharmacogenomics Focus Cogenics emphasizes pharmacogenomics discovery and validation, presenting a pathway to engage biotech and pharma customers seeking biomarker discovery, companion diagnostics, and precision medicine programs.

Mid-market Positioning Revenue in the range of 10–25 million with a specialized service portfolio positions Cogenics as a mid-market partner for mid-to-large life sciences companies seeking specialized genomics capabilities without engaging top-tier CROs.

Established Expertise Leveraging 18 years of genomics experience across brands, plus capabilities in DNA/RNA workstreams, sequencing, cell bank characterization, and biobanking, offers a compelling value proposition for risk-averse customers prioritizing quality and regulatory compliance.